Home/Filings/4/0000899243-22-013466
4//SEC Filing

Korn Jerald 4

Accession 0000899243-22-013466

CIK 0001571498other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 6:48 PM ET

Size

5.8 KB

Accession

0000899243-22-013466

Insider Transaction Report

Form 4
Period: 2022-04-01
Korn Jerald
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-01+800,000800,000 total
    Exercise: $1.14Exp: 2032-03-31Common Stock (800,000 underlying)
Footnotes (2)
  • [F1]This equity award was not granted pursuant to any pre-existing equity incentive plan of Epizyme, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
  • [F2]This option was granted on April 1, 2022 with respect to 800,000 shares of Common Stock of the Company, with 25% vesting on April 1, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001782282

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:48 PM ET
Size
5.8 KB